Corton Capital’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Buy |
+28,755
| New | +$193K | 0.23% | 249 |
|
|
2024
Q4 | – | Sell |
-57,849
| Closed | -$924K | – | 641 |
|
|
2024
Q3 | $924K | Buy |
57,849
+2,876
| +5% | +$46K | 0.45% | 6 |
|
|
2024
Q2 | $783K | Buy |
54,973
+13,831
| +34% | +$197K | 0.41% | 5 |
|
|
2024
Q1 | $583K | Buy |
41,142
+12,566
| +44% | +$178K | 0.21% | 115 |
|
|
2023
Q4 | $431K | Buy |
28,576
+18,091
| +173% | +$273K | 0.14% | 207 |
|
|
2023
Q3 | $166K | Sell |
10,485
-7,582
| -42% | -$120K | 0.08% | 337 |
|
|
2023
Q2 | $274K | Buy |
+18,067
| New | +$274K | 0.13% | 238 |
|